Open-label therapeutic trials of biologics in primary Sjögren’s disease reported between 2002 and 2014.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Open_label_therapeutic_trials_of_biologics_in_primary_Sj_246_gren_8217_s_disease_reported_between_2002_and_2014_/1542206
下载链接
链接失效反馈官方服务：
资源简介：
N, number of patients; pSS, primary Sjögren’s syndrome; AECG: American-European Consensus Group criteria for primary Sjögren’s syndrome; SGB, salivary-gland biopsy; Ig, immunoglobulin; MALT, mucosa-associated lymphoid tissue; ESR, erythrocyte sedimentation rate; VAS, visual analogue scale (0–100 mm); RF, rheumatoid factor; MFI, Multidimensional Fatigue Inventory; C4, fraction 4 of complement; ESSDAI, European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index; ESSPRI, EULAR Sjögren's Syndrome Patient Reported Index; SF-36, Short-Form 36-item quality of life questionnaire; SGUS, salivary-gland ultrasound; NA, not applicable; BELISS: Belimumab in primary Sjögren’s Syndrome
Open-label therapeutic trials of biologics in primary Sjögren’s disease reported between 2002 and 2014.
创建时间：
2015-12-03
